Di(Hydroxyethyl)Ether

Di(Hydroxyethyl)Ether

SCHEMBL3207862

O=C(O)CCC(S)c1ccccc1.O=C(O)CCC(S)c1ccccc1.OCCOCCO

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
NAALAD2 Q9Y3Q0 1/20 0.38
CPA3 P15088 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ABCB11 O95342 1/20 0.36
CHRM2 P08172 1/20 0.36
ADRA2A P08913 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
DRD4 P21917 1/20 0.36
HRH2 P25021 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL3192561 0.89 CYP2D6 (0.44) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL877952 0.87 CYP2D6 (0.48) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
Di(Hydroxyethyl)Ether SCHEMBL1171208 0.84 GABBR2 (0.42) CYP2D6ALDH1A1CYP2C19ABCB11CHRM2
SCHEMBL3209366 0.82 ALDH1A1 (0.42) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL3206596 0.82 ALDH1A1 (0.42) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL3209374 0.82 NAALAD2 (0.37) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL3215253 0.81 NAALAD2 (0.44) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
Glycerin SCHEMBL3213893 0.81 ALDH1A1 (0.41) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
Glycerin SCHEMBL3214162 0.81 ALDH1A1 (0.41) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19
Propylene Glycol SCHEMBL3212556 0.79 ALDH1A1 (0.40) CYP2D6ALDH1A1CYP1A2TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029876-A1 POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND SHOWA DENKO K.K. (JP) 2010-02-04 US disclosed
EP-2030989-A1 POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING THIOL COMPOUND Showa Denko K.K. (JP) 2009-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029876-A1 POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND TMT1A, CCNT1, MGMT CYP2D6 4344/4885ALDH1A1 124/4885CYP1A2 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.